Cargando…

Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas

Identification of novel prognostic biomarkers typically requires a large dataset which provides sufficient statistical power for discovery research. To this end, we took advantage of the high‐throughput data from The Cancer Genome Atlas (TCGA) to identify a set of prognostic biomarkers in head and n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Nathan, Khwaja, Shariq S., Baker, Callie M., Gay, Hiram A., Thorstad, Wade L., Daly, Mackenzie D., Lewis, James S., Wang, Xiaowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944889/ https://www.ncbi.nlm.nih.gov/pubmed/27109697 http://dx.doi.org/10.1002/cam4.718

Ejemplares similares

Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck
por: Schell, Amy, et al.
Publicado: (2015)

A prognostic gene expression signature for oropharyngeal squamous cell carcinoma
por: Liu, Xinyi, et al.
Publicado: (2020)

A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy
por: Chin, Re-I, et al.
Publicado: (2021)

Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of care
por: Gabani, Prashant, et al.
Publicado: (2018)

Prediction of radiotherapy response with a 5‐microRNA signature‐based nomogram in head and neck squamous cell carcinoma
por: Chen, Lin, et al.
Publicado: (2018)

An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2021)

An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma
por: Chen, Dayang, et al.
Publicado: (2021)

Predictors of acute throat or esophageal patient reported pain during radiation therapy for head and neck cancer
por: Gay, Hiram A., et al.
Publicado: (2018)

FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma
por: Liang, Huazhen, et al.
Publicado: (2021)

FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis
por: Huang, Junjie, et al.
Publicado: (2021)

Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset
por: Wu, Chaoying, et al.
Publicado: (2020)

Hypoxia promotes the tolerogenic phenotype of plasmacytoid dendritic cells in head and neck squamous cell carcinoma
por: Fan, Cui, et al.
Publicado: (2021)

The Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma
por: Weed, Donald T., et al.
Publicado: (2023)

Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review
por: Swartz, Justin E, et al.
Publicado: (2015)

Mitochondrial DNA copy number is associated with risk of head and neck squamous cell carcinoma in Chinese population
por: Wang, Lihua, et al.
Publicado: (2018)

Adherence of head and neck squamous cell carcinoma patients to tumor board recommendations
por: Rangabashyam, Mahalakshmi S., et al.
Publicado: (2020)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

The prognostic role of C‐reactive protein in patients with head and neck squamous cell carcinoma: A meta‐analysis
por: Chen, Yanglan, et al.
Publicado: (2020)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
por: Chen, Jin‐Hua, et al.
Publicado: (2016)

MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
por: Mei, Zi, et al.
Publicado: (2019)

Proliferative exhausted CD8(+) T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma
por: Cheng, Danni, et al.
Publicado: (2023)

Childhood tonsillectomy alters the primary distribution of HPV‐related oropharyngeal squamous cell carcinoma
por: Altenhofen, Brannon, et al.
Publicado: (2020)

A novel serum microRNA signature to screen esophageal squamous cell carcinoma
por: Huang, Zebo, et al.
Publicado: (2016)

Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma
por: Yamashita, Taku, et al.
Publicado: (2016)

Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD‐L1
por: Zhang, Pei, et al.
Publicado: (2018)

Malignant and Nonmalignant Gene Signatures in Squamous Head and Neck Cancer
por: Worsham, Maria J., et al.
Publicado: (2012)

Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma
por: Li, Cheng, et al.
Publicado: (2020)

Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all‐cause mortality: Results from head and neck 5000, a prospective observational cohort of people with head and neck cancer
por: Beynon, Rhona A., et al.
Publicado: (2018)

Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population––A SEER‐based analysis from 2000 to 2016
por: Taylor, Melissa A., et al.
Publicado: (2021)

Volumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapy
por: Hanamoto, Atsushi, et al.
Publicado: (2014)

The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma
por: Wilson, Harper L., et al.
Publicado: (2020)

Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma
por: Hagiwara, Sumitaka, et al.
Publicado: (2021)

A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
por: Lee, Ji Hyun, et al.
Publicado: (2021)

MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas
por: Chen, Dan, et al.
Publicado: (2013)

Oral hygiene and the overall survival of head and neck cancer patients
por: Chang, Chan‐Chi, et al.
Publicado: (2019)

Active HPV infection and its influence on survival in head and neck squamous-cell cancer
por: Janecka-Widła, Anna, et al.
Publicado: (2020)

KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma
por: Liu, Yi, et al.
Publicado: (2020)

The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence
por: Khwaja, Shariq S., et al.
Publicado: (2018)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_679u38j7vvjq8v67olaqpcmomb